Identifying amnestic mild cognitive impairment in primary care: A feasibility study

Clinical Drug Investigation

Volumn 31, Issue 7, 2011, Pages 483-491

  Doody, Rachelle S ^a   Ferris, Steven H ^b   Salloway, Stephen ^c,d   Meuser, Thomas M ^e   Murthy, Anita K ^f   Li, Chunming ^g   Goldman, Robert ^g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d BUTLER HOSPITAL   (United States)

^e UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^f EISAI INC   (United States)

^g PFIZER INC   (United States)

Author keywords

Alzheimers disease; Cognition disorders; Dementia; Elderly; Memory disorders

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE DELAYED WORD RECALL; AMNESIA; AMNESTIC MILD COGNITIVE IMPAIRMENT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL DEMENTIA RATING SCALE; COGNITIVE DEFECT; CONSENSUS; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC TEST ACCURACY STUDY; FEASIBILITY STUDY; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INTERRATER RELIABILITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MEDICAL INFORMATION; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NO COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMNESIA; COGNITION DISORDERS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; EARLY DIAGNOSIS; FEASIBILITY STUDIES; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; SENSITIVITY AND SPECIFICITY;

EID: 79957830301     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11588810-000000000-00000     Document Type: Article

References (20)

1. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256 (3): 183-94 (Pubitemid 39222988)
2. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56 (3): 303-8 (Pubitemid 29120227)
3. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. Alzheimers Disease Cooperative Study Group. N Engl J Med 2005; 352 (23): 2379-88 (Pubitemid 40958434)
4. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58 (12): 1985-92 (Pubitemid 33143977)
5. Farlow MR. Treatment of mild cognitive impairment (MCI). Curr Alzheimer Res 2009; 6 (4): 362-7
6. Wilkinson D, Sganga A, Stave C, et al. Implications of the Facing Dementia Survey for health care professionals across Europe. Int J Clin Pract 2005 Suppl.; 59 (146): 27-31 (Pubitemid 40333122)
7. Graham DP, Cully JA, Snow AL, et al. The Alzheimers Disease Assessment Scale-Cognitive subscale: normative data for older adult controls. Alzheimer Dis Assoc Disord 2004; 18 (4): 236-40 (Pubitemid 40076155)
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association Press, 2000
9. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimers disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology 1984; 34: 939-44 (Pubitemid 14076461)
10. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43 (11): 2412-4 (Pubitemid 23346995)
11. GrundmanM, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004; 61 (1): 59-66 (Pubitemid 38067415)
12. OBryant SE, Waring SC, Cullum CM, et al. Staging dementia using clinical dementia rating scale sum of boxes scores: a Texas Alzheimers research consortium study. Arch Neurol 2008; 65 (8): 1091-5
13. Salloway S, Ferris S, Kluger A, et al. Efficacy of donepezil in mild cognitive impairment: a randomized placebocontrolled trial. Neurology 2004; 63 (4): 651-7 (Pubitemid 39100820)
14. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J PsychiatrRes 1975; 12 (3): 189-98
15. Feher EP, Mahurin RK, Doody RS, et al. Establishing the limits of the mini-mental state: examination of subtests. Arch Neurol 1992; 49 (1): 87-92
16. Cicchetti DV, Allison T. A new procedure for assessing reliability of scoring EEG sleep recordings. Am J EEG Technol 1971; 11: 101-9
17. Boustani M, Callahan CM, Unverzagt FW, et al. Implementing a screening and diagnosis program for dementia in primary care. J Gen InternMed 2005; 20 (7): 572-7 (Pubitemid 41026239)
18. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimers disease. Arch Neurol 2001; 58: 397-405 (Pubitemid 32217456)
19. Park KW, Pavlik VN, Rountree SD, et al. Is functional decline necessary for a diagnosis of Alzheimers disease? Dement Geriatr Cogn Disord 2007; 24 (5): 375-9 (Pubitemid 350036694)
20. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment,MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53 (4): 695-9 (Pubitemid 41623495)